Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Bayer Medical: Multistix Urinalysis Strips for Renal Disease Detection
August 5, 2002
- GL on Subarachnoidal Hemorrhages Prepared by Korosho Study Group
July 29, 2002
- Bayer Wants to Keep 2-3% Increase in Adalat Sales
July 29, 2002
- Public Health Research Center Initiates Clinical Study on Breast Cancer
July 29, 2002
- Kuraya Sanseido Aims at Operating Profit Ratio of 2%
July 29, 2002
- Press Seminar
July 29, 2002
- Fukujin Agrees on Prices with Only 20% of Hospitals by End of June
July 29, 2002
- Takara Bio to Develop New Gene Detection System with Nanosphere
July 29, 2002
- Taiyo Pharm Beefs Up Contract Manufacturing Business
July 29, 2002
- Roche Diagnostics: Simple Blood Glucose Determination System, Accu-Chek Active
July 29, 2002
- BUSINESS NEWS IN BRIEF
July 29, 2002
- Eiken, Sysmex Tie Up to Market Urinarysis System in China
July 29, 2002
- Major Domestic Firms Feel Cool to Pfizer's Move
July 29, 2002
- InCROM Establishes EuCROM to Handle CRO Business in Europe
July 29, 2002
- CORPORATE ROUNDUP NEWS IN BRIEF
July 29, 2002
- MEDICAL DEVICE NEWS IN BRIEF
July 29, 2002
- 4.3% of ex-Koseisho Officials Were Aware of Risk of Hepatitis Due to Fibrinogen
July 29, 2002
- WORLD NEWS IN BRIEF
July 29, 2002
- Health Minister Concerned about Delay in Domestic R&D
July 29, 2002
- Nippon Kayaku Not to Spin Off Non-Pharma Business: Mr Nakamura
July 29, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…